ATON
ATON
NASDAQ · Biotechnology

Alphaton Capital Corp

$0.30
-0.03 (-10.36%)
Financial Highlights (FY 2025)
Revenue
3.42M
Net Income
-386,907
Gross Margin
63.4%
Profit Margin
-11.3%
Rev Growth
+21.7%
D/E Ratio
0.38
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 63.4% 63.4% 63.4%
Operating Margin -13.8% -15.8% -14.0%
Profit Margin -11.3% -10.9% -12.5%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 3.42M 3.23M 3.00M
Gross Profit 2.16M 2.05M 1.90M
Operating Income -472,897 -510,920 -418,466
Net Income -386,907 -351,594 -373,147
Gross Margin 63.4% 63.4% 63.4%
Operating Margin -13.8% -15.8% -14.0%
Profit Margin -11.3% -10.9% -12.5%
Rev Growth +21.7% +15.6% +5.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.03M 1.91M 2.41M
Total Equity 5.29M 6.20M 5.71M
D/E Ratio 0.38 0.31 0.42
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -622,705 -634,407 -526,103
Free Cash Flow -366,603 -274,517 -229,625